Thus, these data strongly suggest that PRMT5 regulates EGFR/AKT/β‐catenin signalling, which probably contributes to PRMT5‐induced EMT in pancreatic cancer cells. The gene discussed is EGFR; the disease is pancreatic neoplasm.